Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients
Clinical trial NCT01776411 · COMPLETED
Trial details
- NCT number
- NCT01776411
- Sponsor
- Mundipharma K.K.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2016-03-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.